GlassScriptPhysician profile
Thomas A Williams, JR.
NPI 1932194966
$13,786.61
in general payments reported to CMS, 2019-2025
28 companies · $1,151 in 2025
The $1,151 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,187 · 2020: $531 · 2021: $1,545 · 2022: $1,499 · 2023: $3,316 · 2024: $2,557 · 2025: $1,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,985 · Travel and Lodging: $2,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,984.68 |
| Travel and Lodging | $2,040.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,415.31 | 2019-2025 | Versacross Access Solution, Rhythmia Mapping System, Farapulse |
| Medtronic, INC. | $2,220.95 | 2021-2025 | Micra, Symplicity G3, Cobalt Dr Mri Surescan |
| Impulse Dynamics (USA) INC. | $971.40 | 2023-2025 | Optimizer, Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $872.25 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $660.04 | 2019-2023 | Xarelto |
| Amgen INC. | $581.83 | 2019-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $514.07 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $290.12 | 2019-2023 | |
| Philips North America LLC | $280.70 | 2023-2025 | Igt Devices Undivided, Lm Undivided, (P88) Igt Devices Fm |
| Novartis Pharmaceuticals Corporation | $260.10 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $225.89 | 2022-2023 | Verquvo |
| Cardiva Medical, INC. | $202.08 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Astellas Pharma US INC | $178.26 | 2019-2022 | |
| Abbott Laboratories | $151.87 | 2019-2022 | |
| Atricure, INC. | $131.70 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $125.12 | 2019-2020 | |
| Abiomed | $94.70 | 2024 | Impella |
| Lundbeck LLC | $91.61 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $79.88 | 2019-2022 | |
| Amarin Pharma, INC. | $71.13 | 2019-2020 | |
| Cvrx, INC. | $65.58 | 2023 | Barostim Neo System |
| Ethicon US, LLC | $65.18 | 2024 | Vistaseal |
| Sanofi-Aventis U.S. LLC | $57.66 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.46 | 2022-2023 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $45.06 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.75 | 2022 | |
| Getinge USA Sales, LLC | $23.62 | 2023 | Sensation 7fr. 34cc Iab |
| Catheter Precision INC. | $22.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.